Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

DR Wang, XL Wu, YL Sun - Signal transduction and targeted therapy, 2022 - nature.com
Cancers are highly complex diseases that are characterized by not only the overgrowth of
malignant cells but also an altered immune response. The inhibition and reprogramming of …

Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

RR Ramjiawan, AW Griffioen, DG Duda - Angiogenesis, 2017 - Springer
Angiogenesis is defined as the formation of new blood vessels from preexisting vessels and
has been characterized as an essential process for tumor cell proliferation and viability. This …

COVID-19 vaccines: an overview of different platforms

D Kudlay, A Svistunov - Bioengineering, 2022 - mdpi.com
Vaccination is one of the key strategies to stop the COVID-19 pandemic. This review aims to
evaluate the current state of vaccine development and to determine the issues that merit …

[HTML][HTML] Nanobody-based delivery systems for diagnosis and targeted tumor therapy

Y Hu, C Liu, S Muyldermans - Frontiers in immunology, 2017 - frontiersin.org
The development of innovative targeted therapeutic approaches are expected to surpass the
efficacy of current forms of treatments and cause less damage to healthy cells surrounding …

Vaccine candidates against coronavirus infections. Where does COVID-19 stand?

J Al-Kassmy, J Pedersen, G Kobinger - Viruses, 2020 - mdpi.com
Seven years after the Middle East respiratory syndrome (MERS) outbreak, a new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) made its first appearance in a food …

[HTML][HTML] Theranostics in immuno-oncology using nanobody derivatives

Q Lecocq, Y De Vlaeminck, H Hanssens… - Theranostics, 2019 - ncbi.nlm.nih.gov
Targeted therapy and immunotherapy have become mainstream in cancer treatment.
However, only patient subsets benefit from these expensive therapies, and often responses …

Mannose in vaccine delivery

UJ Nahar, I Toth, M Skwarczynski - Journal of Controlled Release, 2022 - Elsevier
Adjuvants and vaccine delivery systems are used widely to improve the efficacy of vaccines.
Their primary roles are to protect antigen from degradation and allow its delivery and uptake …

Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy

YJ Yoo, CH Lee, SH Park, YT Lim - Journal of Controlled Release, 2022 - Elsevier
Although cancer immunotherapy has emerged as a novel cancer treatment modality, it still
suffers from low therapeutic efficacy in clinics due to the presence of a low number of …

Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

S Van Lint, D Renmans, K Broos, L Goethals… - Cancer immunology …, 2016 - AACR
Modulating the activity of tumor-infiltrating dendritic cells (TiDC) provides opportunities for
novel cancer interventions. In this article, we report on our study of the uptake of mRNA by …

Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy

Y Lu, Y Shi, J You - Journal of Controlled Release, 2022 - Elsevier
The cross presentation of exogenous antigen (Ag) by dendritic cells (DCs) facilitates a
diversified mode of T-cell activation, orchestrates specific humoral and cellular immunity …